Literature DB >> 20417575

Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

David S Miller1.   

Abstract

ATP-binding cassette (ABC) transporters are important selective elements of the blood-brain barrier. They line the luminal plasma membrane of the brain capillary endothelium, facing the vascular space, and both protect the central nervous system from entry of neurotoxicants and limit the access of therapeutic drugs to the brain parenchyma. Recent studies highlight the multiple signaling pathways through which the expression and activity of P-glycoprotein and other ABC transporters are modulated in response to xenobiotics, stress and disease. The results show that increased transporter expression occurs in response to signals that activate specific transcription factors, including pregnane-X receptor, constitutive androstane receptor, nuclear factor-kappaB and activator protein-1, and that reduced transporter activity occurs rapidly and reversibly in response to signaling through Src kinase, protein kinase C and estrogen receptors. A detailed understanding of such regulation can provide the basis for improved neuroprotection and enhanced therapeutic drug delivery to the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417575      PMCID: PMC2882496          DOI: 10.1016/j.tips.2010.03.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  78 in total

Review 1.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

2.  17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.

Authors:  Anika M S Hartz; Anne Mahringer; David S Miller; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-10       Impact factor: 6.200

Review 3.  ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

Authors:  Sarah Vautier; Christine Fernandez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-11       Impact factor: 4.481

4.  Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.

Authors:  Robert R Rigor; Brian T Hawkins; David S Miller
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-03       Impact factor: 6.200

5.  Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs.

Authors:  Annalisa Nannelli; Francesco Rossignolo; Roberto Tolando; Paolo Rossato; Mario Pellegatti; Vincenzo Longo; P Giovanni Gervasi
Journal:  Mol Cell Biochem       Date:  2009-10-22       Impact factor: 3.396

Review 6.  Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy?

Authors:  Anika M S Hartz; Sylvia Notenboom; Bjorn Bauer
Journal:  Drug News Perspect       Date:  2009-09

7.  Glutathione depletion upregulates P-glycoprotein expression at the blood-brain barrier in rats.

Authors:  Jing Wu; Hui Ji; Ying Yu Wang; Ying Wang; Yong Qi Li; Wei Guang Li; Yan Long; Yuan Zheng Xia; Hao Hong
Journal:  J Pharm Pharmacol       Date:  2009-06       Impact factor: 3.765

8.  Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells.

Authors:  Yu Zhong; Bernhard Hennig; Michal Toborek
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

9.  Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.

Authors:  Anika M S Hartz; David S Miller; Björn Bauer
Journal:  Mol Pharmacol       Date:  2010-01-25       Impact factor: 4.436

10.  Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.

Authors:  Brian T Hawkins; Destiny B Sykes; David S Miller
Journal:  J Neurosci       Date:  2010-01-27       Impact factor: 6.167

View more
  127 in total

1.  Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels.

Authors:  Hisamichi Naito; Hiroyasu Kidoya; Susumu Sakimoto; Taku Wakabayashi; Nobuyuki Takakura
Journal:  EMBO J       Date:  2011-12-16       Impact factor: 11.598

Review 2.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

3.  Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib.

Authors:  Mukul Minocha; Varun Khurana; Bin Qin; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2012-06-09       Impact factor: 5.875

Review 4.  Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.

Authors:  Tristan M Sissung; Sarah M Troutman; Tessa J Campbell; Heather M Pressler; Hyeyoung Sung; Susan E Bates; William D Figg
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

5.  Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.

Authors:  Margaret E Tome; Charles P Schaefer; Leigh M Jacobs; Yifeng Zhang; Joseph M Herndon; Fabian O Matty; Thomas P Davis
Journal:  J Neurochem       Date:  2015-04-21       Impact factor: 5.372

6.  Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.

Authors:  Long Sheng; Maoming Xiong; Cong Li; Xiangling Meng
Journal:  Pathol Oncol Res       Date:  2013-12-11       Impact factor: 3.201

7.  1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.

Authors:  Matthew R Durk; Gary N Y Chan; Christopher R Campos; John C Peart; Edwin C Y Chow; Eason Lee; Ronald E Cannon; Reina Bendayan; David S Miller; K Sandy Pang
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

8.  Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells.

Authors:  Richard S Beard; Ricci J Haines; Kevin Y Wu; Jason J Reynolds; Stephanie M Davis; John E Elliott; Nikolay L Malinin; Victor Chatterjee; Byeong J Cha; Mack H Wu; Sarah Y Yuan
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

9.  Cilostazol strengthens barrier integrity in brain endothelial cells.

Authors:  Shoji Horai; Shinsuke Nakagawa; Kunihiko Tanaka; Yoichi Morofuji; Pierre-Oliver Couraud; Maria A Deli; Masaki Ozawa; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.046

10.  Effects of deep hypothermic circulatory arrest on the blood brain barrier in a cardiopulmonary bypass model--a pilot study.

Authors:  Karsten Bartels; Qing Ma; Talaignair N Venkatraman; Christopher R Campos; Lindsay Smith; Ronald E Cannon; Mihai V Podgoreanu; Christopher D Lascola; David S Miller; Joseph P Mathew
Journal:  Heart Lung Circ       Date:  2014-05-23       Impact factor: 2.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.